Provia LaboratoriesT Expands its Stem Cell Portfolio to Amniotic Fluid, Chorionic Villi, and Placenta

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    PRWeb (USA), September 29, 2016, 2pp
  • Additional Information
    • Abstract:
      The proper collection, transport, processing, testing and preservation of stem cells is a crucial and significant part of the regenerative medicine value chain and stem cell therapy. The stem cell therapy market is estimated to exceed $180B in 2030 (Frost and Sullivan). In preparation for a future where stem cell therapies are a significant part of healthcare, companies have provided stem cell banking services from bone marrow and umbilical cord blood for over two decades...